The drug maker Novartis on Wednesday said the company has shipped doses of the seasonal flu vaccine to the U.S. "ahead of schedule as the current swine flu pandemic is likely to trigger a rise in demand," Reuters reports (Reid, 8/5).

This article is republished with kind permission from our friends at The Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives, or sign up for email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is published for Kaisernetwork, a free service of The Henry J. Kaiser Family Foundation. 2009 Advisory Board Company and Kaiser Family Foundation. All rights reserved.